Researchers from the Institute of Industrial Science, The University of Tokyo improve the accuracy of land surface models in ...

Gilead and Novo Nordisk have announced their drug combinations for the fatty liver disease known as NASH checked out in a mid-stage proof-of-concept study. The companies said the trial met its primary ...

Over half of the world's population now lives in cities, a figure expected to rise to nearly 70% by 2050, posing significant challenges for jobs, housing, and infrastructure. The World Bank is ...